Company intelligence / Profile preview

Proteros Biostructures

Planegg-Martinsried, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

Proteros Biostructures is a private, service-focused early drug discovery contract research organization providing structural biology, biophysics, screening and medicinal chemistry support to pharma and biotech clients; it does not appear to run its own clinical-stage therapeutic pipeline but enables clients' pre-clinical and clinical programs through structure-based drug discovery services.[1][2][4][6]

Modalities: Small moleculeBiologicProtein
Industry: Drug Discovery Services

Partnerships

Multiple global pharmaceutical and biotechnology companies as discovery services clients (more than 80 international pharma, biotech and agricultural companies reported in earlier descriptions).[2][3][4]

Beyond the preview

Go deeper on Proteros Biostructures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteros Biostructures.

Explore the full profile